Uptake of the respiratory syncytial virus (RSV) vaccine during pregnancy is not linked to increased risk of adverse perinatal health outcomes among vaccinated women, according to research at City St George’s and published in BMJ Open.
RSV vaccine uptake in pregnancy linked to perinatal outcomes and health inequities
